Sitadapa M 100/10/1000 Tablet ER
Marketer
Macleods Pharmaceuticals Pvt Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (1000mg) + Sitagliptin (100mg)
Overview Sitadapa M 100/10/1000 Tablet ER
Diabetol-M 100/10/1000 Extended-Release tablets are a combined medication designed to manage blood glucose. This medication, used alongside diet and exercise, improves glycemic control in adult patients with type 2 diabetes. It enhances insulin effectiveness, thus reducing blood sugar. Diabetol-M 100/10/1000 ER can be ingested with or without food, at any time, but consistency in daily timing is recommended. Dosage should be determined by your physician; discontinuation without their approval may elevate blood sugar, increasing the risk of severe complications such as renal impairment and vision loss. This medication forms only one component of a comprehensive treatment plan encompassing a healthy diet, regular physical activity, and weight management as advised by your doctor. Frequent adverse events include urinary tract infections, nasal congestion, pharyngitis, and upper respiratory infections. Adequate hydration is crucial to mitigate dehydration. Genital fungal infections may occur in some individuals; good hygiene practices help minimize this risk. Prior to commencing Diabetol-M 100/10/1000 ER, inform your doctor of any pre-existing kidney or liver conditions, urinary tract infections, or diuretic usage. Pregnant or lactating women should consult their physician before taking this medication. Limit alcohol consumption while using this medicine, as this could intensify some side effects. Regular blood glucose monitoring is essential throughout the treatment period.
Primary Ingredients of Sitadapa M 100/10/1000 Tablet ER
No information provided. Unable to rephrase.
Uses of Sitadapa M 100/10/1000 Tablet ER
Managing type 2 diabetes
Major Benefits of Sitadapa M 100/10/1000 Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Sitadapa M 100/10/1000 Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or not, but consistent daily timing is recommended.
Common Side effects of Sitadapa M 100/10/1000 Tablet ER:
- Diarrhea
- Nausea
- Vomiting
- Flatulence
- Polyuria
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Headache
- Hypoglycemia (low blood glucose level)
- Cough
How to use Sitadapa M 100/10/1000 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Sitadapa M 100/10/1000 Extended-Release tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, however, consistent timing is recommended.
How Sitadapa M 100/10/1000 Tablet ER works:
Sitadapa M 100/10/1000 Extended-Release tablets combine three anti-hyperglycemic agents. Dapagliflozin promotes glucose elimination through the urine, thereby lowering blood sugar. Metformin reduces glucose absorption from ingested food and hepatic glucose production. Furthermore, it enhances insulin sensitivity, improving the body's natural glucose regulation. Sitagliptin manages blood glucose by stimulating incretin secretion, prompting the pancreas to release more insulin and suppressing excessive hepatic glucose production.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol and Sitadapa M 100/10/1000 Tablet ER is undetermined; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on Sitadapa M 100/10/1000 Tablet ER use in pregnancy is absent. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Sitadapa M 100/10/1000 Tablet ER while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Extended-release Sitadapa M 100/10/1000 tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Sitadapa M 100/10/1000 Tablet ER in individuals with renal impairment. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Sitadapa M 100/10/1000 Tablet ER in individuals with hepatic impairment. Seek medical advice.
What if you forget to take Sitadapa M 100/10/1000 Tablet ER :
Should you forget to take a Sitadapa M 100/10/1000 Tablet ER, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Sitadapa M 100/10/1000 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |






